Mitochondrial Hsp60 Chaperonopathy Causes an Autosomal-Recessive Neurodegenerative Disorder Linked to Brain Hypomyelination and Leukodystrophy

Daniella Magen, Costa Georgopoulos, Peter Bross, Debbie Ang, Yardena Segev, Dorit Goldsher, Alexandra Nemirovski, Eli Shahar, Sarit Ravid, Anthony Luder, Bayan Heno, Ruth Gershoni-Baruch, Karl Skorecki, Hanna Mandel

Research output: Contribution to journalArticlepeer-review

179 Scopus citations

Abstract

Hypomyelinating leukodystrophies (HMLs) are disorders involving aberrant myelin formation. The prototype of primary HMLs is the X-linked Pelizaeus-Merzbacher disease (PMD) caused by mutations in PLP1. Recently, homozygous mutations in GJA12 encoding connexin 47 were found in patients with autosomal-recessive Pelizaeus-Merzbacher-like disease (PMLD). However, many patients of both genders with PMLD carry neither PLP1 nor GJA12 mutations. We report a consanguineous Israeli Bedouin kindred with clinical and radiological findings compatible with PMLD, in which linkage to PLP1 and GJA12 was excluded. Using homozygosity mapping and mutation analysis, we have identified a homozygous missense mutation (D29G) not previously described in HSPD1, encoding the mitochondrial heat-shock protein 60 (Hsp60) in all affected individuals. The D29G mutation completely segregates with the disease-associated phenotype. The pathogenic effect of D29G on Hsp60-chaperonin activity was verified by an in vivo E. coli complementation assay, which demonstrated compromised ability of the D29G-Hsp60 mutant protein to support E. coli survival, especially at high temperatures. The disorder, which we have termed MitCHAP-60 disease, can be distinguished from spastic paraplegia 13 (SPG13), another Hsp60-associated autosomal-dominant neurodegenerative disorder, by its autosomal-recessive inheritance pattern, as well as by its early-onset, profound cerebral involvement and lethality. Our findings suggest that Hsp60 defects can cause neurodegenerative pathologies of varying severity, not previously suspected on the basis of the SPG13 phenotype. These findings should help to clarify the important role of Hsp60 in myelinogenesis and neurodegeneration.

Original languageEnglish
Pages (from-to)30-42
Number of pages13
JournalAmerican Journal of Human Genetics
Volume83
Issue number1
DOIs
StatePublished - 11 Jul 2008
Externally publishedYes

Bibliographical note

Funding Information:
We are very grateful to the families with MitCHAP-60 disease for participating in this study. We thank Eli Sprecher and Sarah Selig for discussions and useful suggestions, Guennady Yudkovsky for technical assistance, and the National Laboratory for the Genetics of Israeli Populations for providing control DNA samples for RFLP analysis. This research was supported by grants from the Barry Rose Fund and the Veronique Elek Fund of the Canadian Technion Society, and the Rosalinde and Arthur Gilbert Foundation of the American Technion Society.

Funding

We are very grateful to the families with MitCHAP-60 disease for participating in this study. We thank Eli Sprecher and Sarah Selig for discussions and useful suggestions, Guennady Yudkovsky for technical assistance, and the National Laboratory for the Genetics of Israeli Populations for providing control DNA samples for RFLP analysis. This research was supported by grants from the Barry Rose Fund and the Veronique Elek Fund of the Canadian Technion Society, and the Rosalinde and Arthur Gilbert Foundation of the American Technion Society.

FundersFunder number
American Technion Society
Barry Rose Fund
Canadian Technion Society
Veronique Elek Fund

    Fingerprint

    Dive into the research topics of 'Mitochondrial Hsp60 Chaperonopathy Causes an Autosomal-Recessive Neurodegenerative Disorder Linked to Brain Hypomyelination and Leukodystrophy'. Together they form a unique fingerprint.

    Cite this